| Tue, Oct 27, 2009 | | • | Life Technologies says demand held up in 3Q
AP (Tue, Oct 27)
| | • | Life Technologies net income, revenue double
at MarketWatch (Tue, Oct 27)
| | • | LIFE TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure
EDGAR Online (Tue, Oct 27)
| | • | Life Technologies Announces Third Quarter 2009 Results
Business Wire (Tue, Oct 27)
| | • | Q3 2009 Life Technologies Corporation Earnings Release - Before Market Open
CCBN (Tue, Oct 27)
| | • | Trading Review for Discovery Laboratories Inc. Issued by Beacon Equity
GlobeNewswire (Tue, Oct 27)
| | • | Trading Outlook for Elan Corp. Plc. Issued by InvestorSoup.com
GlobeNewswire (Tue, Oct 27)
| | Mon, Oct 26, 2009 | | • | Phase III Trial Expenses For Diabetes Treatments Now Forcing Acquisitions Of Small Cap Biotech Firms: FDA Has "Raised The Bar" For Approval Due To Recent Cardiovascular Issues
Wall Street Transcript (Mon, Oct 26)
| | Fri, Oct 23, 2009 | | • | Global Healthcare Companies Investor 100% Overweighted To Biotech As Wave Of Acquisitions By Large Pharma Picks Up Pace
Wall Street Transcript (Fri, Oct 23)
| | Thu, Oct 22, 2009 | | • | Global Commercialization of Applied Biosystems 3500 Series Genetic Analyzers Sets New Standards for Throughput, Data Quality and Ease-of-Use
Business Wire (Thu, Oct 22)
| | Wed, Oct 21, 2009 | | • | Life Technologies Delivers Enhanced Next-Generation Genomic Analysis Technology for Large-Scale Resequencing Projects
Business Wire (Wed, Oct 21)
| | • | Trading Review for Inovio Biomedical Corp. Issued by InvestorSoup.com
GlobeNewswire (Wed, Oct 21)
| | Tue, Oct 20, 2009 | | • | Neurogenic Orthostatic Hypotension Treatment Should Pass Phase III Trials: Catalyst For Biotech Stock Says Wedbush Morgan Analyst
Wall Street Transcript (Tue, Oct 20)
| | • | CEO Interview: Advaxis - Thomas Moore
Wall Street Transcript (Tue, Oct 20)
| | • | Trading Review for CEL-SCI Corp. Issued by InvestorSoup.com
GlobeNewswire (Tue, Oct 20)
| | Wed, Oct 14, 2009 | | • | Life Technologies Announces Appointment of Sales Vice President for Next Generation Sequencing
Business Wire (Wed, Oct 14)
| | Tue, Oct 13, 2009 | | • | Applied Biosystems Advances 21st Century Forensics with Innovative DNA Analysis Solutions
Business Wire (Tue, Oct 13)
| | Wed, Oct 7, 2009 | | • | Beacon Equity Issues Trading Overview for Repros Therapeutics Inc.
GlobeNewswire (Wed, Oct 7)
| | Tue, Oct 6, 2009 | | • | 3 Health-Care Stocks That'll Thrive Through Reform: Manager
at CNBC (Tue, Oct 6)
| | • | Baylor College of Medicine Expands Fleet of SOLiD Systems to Expand Cancer Studies and Other Complex Human Diseases
Business Wire (Tue, Oct 6)
| | • | Life Technologies Sets Third Quarter 2009 Earnings Release Date for Tuesday, October 27, 2009
Business Wire (Tue, Oct 6)
| | Mon, Oct 5, 2009 | | • | Kellogg Asset Management Picks Amgen and Baxter As Large Cap Growth Winners: Denosumab and GAMMAGARD Will Unlock The Upside For These Two Health Care Stocks
Wall Street Transcript (Mon, Oct 5)
| | Tue, Sep 29, 2009 | | • | Life Technologies Foundation Awards $1.7 Million in Grants to Advance Science
Business Wire (Tue, Sep 29)
| | Mon, Sep 28, 2009 | | • | Biotechnology Real Estate: Industry Expert Jerry Doctrow Calls This A Sweet Spot For Investors In This Market
Wall Street Transcript (Mon, Sep 28)
| | • | Life Technologies and febit Team to Offer New Solution for Targeted Re-sequencing in Large-scale Genomic Studies
Business Wire (Mon, Sep 28)
|
Add LIFE News to My Yahoo!:
 
| |
|
0.01% Nasdaq 
Headlines
